Drawing for HYALASPHERES

USPTO serial 77088355

HYALASPHERES

Reviewed by CopyMark Law Group

Status 601
Filing date
Status date
Registration date
—
Examiner
BESCH, JAY C
Law office
TMEG LAW OFFICE 108 - EXAMINING ATTORNEY ASSIGNED

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with HYALASPHERES?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
001Hyaluronic acid hydrogel nanoparticles used in the manufacture of cosmetic and pharmaceutical productsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 28, 2007MAB1ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT—
Jun 28, 2007ABN1ABANDONMENT - EXPRESS MAILED—
Jun 27, 2007EXARTEAS EXPRESS ABANDONMENT RECEIVED—
May 21, 2007GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 21, 2007CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 9, 2007DOCKASSIGNED TO EXAMINER—
Jan 25, 2007NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance